I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Alenazi, Mohammed W.
240
results:
Search for persons
X
Format
Online (240)
Mediatypes
Articles (Online) (220)
Bookchapter (Online) (10)
OpenAccess-fulltext (10)
Sorted by: Relevance
Sorted by: Year
?
1
Type I interferon autoantibodies in hospitalized patients w..:
Alotaibi, Faizah
;
Alharbi, Naif Khalaf
;
Rosen, Lindsey B.
...
Influenza and Other Respiratory Viruses. 17 (2023) 3 - p. , 2023
Link:
https://doi.org/10.1111/..
?
2
Salivary Antibody Responses to Two COVID-19 Vaccines follow..:
Alkharaan, Hassan
;
Al-Qarni, Hatem
;
Aldosari, Muath A.
...
Vaccines. 11 (2023) 4 - p. 744 , 2023
Link:
https://doi.org/10.3390/..
?
3
Seroprevalence of COVID-19 in Riyadh city during the early ..:
Alenazi, Mohammed W.
;
Algaisi, Abdullah
;
Zowawi, Hosam M.
...
Saudi Journal of Biological Sciences. 29 (2022) 6 - p. 103282 , 2022
Link:
https://doi.org/10.1016/..
?
4
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate..:
Bosaeed, Mohammad
;
Balkhy, Hanan H
;
Almaziad, Sultan
...
The Lancet Microbe. 3 (2022) 1 - p. e11-e20 , 2022
Link:
https://doi.org/10.1016/..
?
5
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidat..:
Alharbi, Naif Khalaf
;
Aljamaan, Fahad
;
Aljami, Haya A.
...
Vaccines. 10 (2022) 8 - p. 1330 , 2022
Link:
https://doi.org/10.3390/..
?
6
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia:
Alharbi, Naif Khalaf
;
Alghnam, Suliman
;
Algaissi, Abdullah
...
Journal of Infection and Public Health. 14 (2021) 7 - p. 832-838 , 2021
Link:
https://doi.org/10.1016/..
?
7
Type I interferon autoantibodies in hospitalized patients w..:
Alotaibi, Faizah
;
Alharbi, Naif Khalaf
;
Rosen, Lindsey B
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028524/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
8
Salivary Antibody Responses to Two COVID-19 Vaccines follow..:
Hassan Alkharaan
;
Hatem Al-Qarni
;
Muath A. Aldosari
...
https://www.mdpi.com/2076-393X/11/4/744. , 2023
Link:
https://doi.org/10.3390/..
?
9
Salivary Antibody Responses to Two COVID-19 Vaccines follow..:
Hassan Alkharaan
;
Hatem Al-Qarni
;
Muath A. Aldosari
...
Therapeutic Vaccines and Antibody Therapeutics. , 2023
Link:
https://doi.org/10.3390/..
?
10
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidat..:
Naif Khalaf Alharbi
;
Fahad Aljamaan
;
Haya A. Aljami
...
https://www.mdpi.com/2076-393X/10/8/1330. , 2022
Link:
https://doi.org/10.3390/..
?
11
Seroprevalence of COVID-19 in Riyadh city during the early ..:
Mohammed W. Alenazi
;
Abdullah Algaisi
;
Hosam M. Zowawi
...
http://www.sciencedirect.com/science/article/pii/S1319562X2200198X. , 2022
Link:
https://doi.org/10.1016/..
?
12
Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidat..:
Naif Khalaf Alharbi
;
Fahad Aljamaan
;
Haya A. Aljami
...
Veterinary Vaccines. , 2022
Link:
https://doi.org/10.3390/..
?
13
Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia:
Naif Khalaf Alharbi
;
Suliman Alghnam
;
Abdullah Algaissi
...
http://www.sciencedirect.com/science/article/pii/S1876034121000988. , 2021
Link:
https://doi.org/10.1016/..
?
14
Safety and immunogenicity of ChAdOx1 MERS vaccine candidate..:
Mohammad Bosaeed, MD
;
Hanan H Balkhy, ProfMD
;
Sultan Almaziad, MD
...
http://www.sciencedirect.com/science/article/pii/S2666524721001932. , 2022
Link:
https://doi.org/10.1016/..
?
15
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Followi..:
Alharbi, Naif Khalaf
;
Al-Tawfiq, Jaffar A
;
Alwehaibe, Amal
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348632/. , 2022
Link:
http://www.ncbi.nlm.nih...
1-15
